期刊文献+

a-β_2GP1、ACA在早期先兆流产患者妊娠丢失中的临床意义 被引量:1

Clinical Significance of a-β_2GP1, ACA in Pregnancy Loss in Patients with Threaten Abortion in the First Trimester
下载PDF
导出
摘要 目的评价a-β2GP1、ACA在早期先兆流产患者妊娠丢失中的临床意义。方法采用前瞻性病例对照研究,对80例8~12周先兆流产患者(研究组)和35例正常孕妇(对照组)的血清a-β2GP1、ACA进行检测,并随访至妊娠结束。研究组根据妊娠结局分为足月分娩组以及妊娠丢失组。结果 80例先兆流产患者中,早期妊娠丢失者46例(57.5%),足月分娩者34例(42.5%)。早期流产者平均孕周为(10.5±1.2)周。a-β2GP1IgM型阳性率在妊娠丢失组(41.3%)较其他两组(14.7%,0%)更多见,差异有显著性意义(P<0.05)。IgG型各组间无明显差异。妊娠丢失组ACAIgM、IgG型阳性率较其它两组高,但差异无显著性差异。结论 a-β2GP1IgM会增加早期先兆流产患者妊娠丢失的风险。 Objective To evalue the clinical significance of a-β2GP1, ACA in pregnancy loss in women with threaten abortion in the first trimester. Methods Anti-β2-glycoprotein I, anticardiolipin antibody was tested in 80 patients with threaten abortion in the first trimester (study group), and 35 healthy pregnant without complicated gestation (control group) and the pregnant outcome was followed up. Study group was divided into pregnancy loss and delivery at term group according to the pregnant outcome. Results Of the 80 patients with threatened abortion, 46 (57.5%) progressed early pregnancy loss and 34 (42.5%) experienced to deliver at term. Among the antibodies evaluated, only anti-β2-glycoprotein 1 IgM isotype was significantly more frequent in those women whose pregnancy resulted in spontaneous abortion (41.3%) than in the other both groups (14.7%, 0%, P 〈0.05). The positive rates of ACA IgM, IgG were higher in pregnancy loss group than the other goups, but without statistic significance (P 〉0.05). Conclusions A-β2GP1 IgM is associated with an increased risk of pregnancy loss in women with threatened abortion in the first trimester.
出处 《临床医学工程》 2012年第10期1684-1685,共2页 Clinical Medicine & Engineering
基金 广东省医学科研基金(A2010268)
关键词 a-β2GP1 ACA 先兆流产 妊娠丢失 A-β2GP1 ACA Threatened abortion Pregnancy loss
  • 引文网络
  • 相关文献

参考文献10

  • 1Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite an- tiphospholipid syndrome (APS) [J] . J Thromb Haemost, 2006, 4 (2) : 295-306.
  • 2Di Simone N, Meroni PL, D'Asta M, et aL Pathogenic role of anti-beta2- glyeoprotein [ on human plaeenta: functional effects related to implanta- tion and roles of heparin [J] . Hum Reprod Update, 2007, 13: 189-196.
  • 3Mezzesimi A, Florio P, Reis FM, et al. The detection of anti-beta2- glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimester [J] . Eur J Obstet Gynecol Reprod Biol, 2007, 133 (2) : 164-168.
  • 4Zammiti W, Mtiraoui N, Kallel C, et aL A case-control study on the association of idiophatic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V [J] . Reproduction, 2006, 131 (4) :817-822.
  • 5Oron G, Ben-Haroush A, Goldfarb R, et al. Contribution of the addi- tion of anti-/32-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome [J] . J Matern Fe- tal Neonatal Med, 2011, 24 (4) : 606-609.
  • 6鲍时华,汪希鹏,林其德,狄文,徐亮,丁传伟,吕彩君.联合多次检测ACA和抗β_2-GPI抗体对复发性流产的诊断价值[J].中国实用妇科与产科杂志,2007,23(10):760-762. 被引量:16
  • 7Xie W, Zhang Y, Bu C, et al. Anti-coagulation effect of Fc fragment against anti-β2-GP1 antibodies in mouse models with APS [J] . Int Immunopharmacol, 2011, 11 (1) : 136-140.
  • 8Lee RM, Branch DW, Silver RM. Immunoglobulin A anti-beta2-gly- coprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death [J] . Am J Obstet Gynecol, 2001, 185 (3) : 748-753.
  • 9Mtiraoui N, Zammiti W, Fekih M, et al. bodies to beta 2-glycoprotein I, annexin of recurrent spontaneous abortion [J] Lupus anticoagulant and anti- V, and cardiolipin as a cause Fertil Steril, 2007, 88 (5) :1458-1461.
  • 10林其德,肖云山.抗磷脂综合征与病理妊娠[J].中国实用妇科与产科杂志,2004,20(5):264-266. 被引量:42

二级参考文献19

  • 1林其德,肖云山.抗磷脂综合征与病理妊娠[J].中国实用妇科与产科杂志,2004,20(5):264-266. 被引量:42
  • 2林其德,周涵春.原因不明性习惯性流产的免疫学诊断与治疗[J].中华妇产科杂志,1993,28(3):143-146. 被引量:41
  • 3林其德,周涵春.复发性流产与自身抗体关系的探讨[J].中华妇产科杂志,1993,28(11):674-677. 被引量:49
  • 4Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gynecol, 2003,101 (6): 1333-1344
  • 5Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol,2001,96(1) :37-50
  • 6Chamley LW. Antiphospholipid antibodies: biological basis and prospects for treatment. J Reprod Immunol, 2002,57(1 ): 185-202
  • 7Voss A, Jacobsen S, Heegaard NH. Association of beta2-glycoprotein IgG and IgM antibodies with thrombosis and thrombocytopenia. Lupus, 2001,10(8): 533-538
  • 8Lockshin MD,Branch DW,Piette JC,et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999,42(50): 1309-1331
  • 9Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun, 2000,15 ( 1 ): 163-172
  • 10Matsuura E,Igarashi M,Igarashi Y,et al.Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies[J].Lupus,1955,4 (Suppl 1):7-13.

共引文献56

同被引文献7

引证文献1

二级引证文献1

;
使用帮助 返回顶部